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Abstract: (1) Background: Onychomycosis (OM) is a fungal nail infection, considered a risk factor for
diabetic foot ulcers. It is associated with changes in quality of life, in terms of pain, self-confidence
and self-esteem. The aim was to translate and adapt the OM quality of life questionnaire “OnyCOE-
tTM–Quality Of Life Questionnaire Onychomycosis (Nail Fungal Condition)”. (2) Methods: This
study followed the guidelines proposed by Beaton et al. (2000), where two English to Portuguese
translations were performed and, after an expert consensus, a common version was obtained. This
was followed by two back-translations. The expert committee achieved semantic equivalence, idioms
and concepts. The pre-test was applied to 49 people. The final version and processed data were sent
to the authors. (3) Results: We adapted terms semantically, modified statements syntactically, altering
items from interrogative to affirmative. (4) Conclusions: The translated version of the “Quality of
life–Onychomycosis” questionnaire suggested that it can be used for further studies to test validity
and reliability in this population.
Keywords: quality of life; onychomycosis; translation; cross-cultural adaptation
1. Introduction
Onychomycosis (OM) is a fungal nail infection, also known as Tinea unguium [1],
with estimated prevalence of 10–14% in the general population [2–4]. Although OM is
considered an aesthetic problem [5], it is recognized as a risk factor, promoter of foot
ulcers and enhancer of acute bacterial cellulitis, particularly in diabetics [6–8]. Despite
the difficulty of drugs to penetrate the nail plate, topical treatment is often preferred
over a systemic approach [9]. These treatments have contraindications associated with
comorbidities, as well as iatrogenic effects [10,11], and a high number of resistance and
reinfection cases [10].
Altogether, OM frequently becomes a chronic health problem with a significant impact
on the quality of life (QOL) of these people [10]. In addition to OM being responsible for
half of all nail disorders [12], it is also considered a skin disorder, with negative social,
psychological and occupational effects [13].
According to a recent review, QOL has been evaluated in people with OM, namely in
randomized clinical trials [11]. The most commonly used instruments for evaluation of
QOL in OM are the OnyCOE-tTM, NailQoL and Drake’s QoL Questionnaire [11]. However,
the OnyCOE-tTM [14] questionnaire is the only psychometrically validated instrument used
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to assess response to treatment through patient-reported outcomes (PRO) [15]. This instru-
ment is composed of 33 items, with 6 multi-item scales and 1 single-item scale, and was
validated through the IRON-CLAD® (a large, randomized multicenter American clinical
trial), present internal consistency reliability by Cronbach’s alpha > 0.84. The Responsive-
ness was good, regarding the treatment satisfaction, symptom frequency, overall problem
and appearance problem (Guyatt’s statistic of 1.72, 1.31, 1.13, and 1.11, respectively) [14,15].
The first study of OM’s impact on patients’ QOL was published in 1993. This was
developed to measure the relationship between QOL and specific aspects of OM, specifi-
cally, physical (pain), psychological (shame) and social problems (isolation). This study
recognized that QOL is negatively affected by OM, namely in terms of mental health, social
interaction, self-confidence, self-esteem, physical discomfort and pain. In this study, per-
sonal concern and social embarrassment were also found to be present, due to fear of nail
exposure [16]. Some studies demonstrate that, although some people with OM can adapt
to this condition, a large portion of them continue to report embarrassment, discomfort and
significant reduction in QOL [11]. While OM is not a significant impediment to work, some
participants have reported losing days of work, with consequent implications [16–18].
In Portugal, prevalence studies estimate rates between 17 and 47% [5,19], which is
above the 10–14% estimated in the general population [2–4]. This discrepancy reinforces
the need to study OM in the Portuguese population to understand the health impact, and
because a previous study reported that the Portuguese geriatric population considered OM
as an aesthetic condition, unless foot problems were present [5].
With this study, it is intended to translate and culturally adapt a questionnaire specifi-
cally designed to measure the consequences of OM reported by patients in the “Quality
Of Life Questionnaire Onychomycosis–Nail Fungal Condition (OnyCOE-tTM)” for the
Portuguese population [14].
2. Materials and Methods
OnyCOE-tTM was translated and adapted according to the guidelines of Beaton et al. [20]
(see details in Table 1). The authorization to translate the scale into Portuguese was
obtained from the authors of the instrument. The questionnaire was developed to assess
the QOL reported by patients with OM. It allows an assessment of symptoms related to
nail involvement, using a Likert scale with six items and five response options, which, due
to the frequency described by patients, reveal the degree of perceived discomfort caused
by this problem. In addition, this questionnaire evaluates problems related to appearance,
using eight items with four answer options. It also has a scale problem related to physical
activities through seven items and four response options. General problems with one item
and four response options are also assessed. The questionnaire also includes a stigma
perception scale with seven items and five answer options and, finally, a satisfaction scale
with three questions and five answer options [14].
A sample of 49 patients was selected from a larger sample of 90 patients that were
involved in a separate OM prevalence study, including all participants that accepted
answering the OnyCOE-tTM questionnaire and consented to being interviewed.
The methodology recommended by Beaton et al. [20] proposed a sequential script of
steps to concretize the translation and cross-cultural adaptation. The methodology used
was separated into stages (I–VI) which is detailed in Table 1.
The expert committee (as recommended for stage IV) was selected from the university
and hospital staff and composed of an English teacher, three PhD level researchers and/or
professors in health sciences, one PhD expert on QOL scales, one PhD student expert in
medical-surgical nursing, two American collaborators responsible for the company that
owns the original scale.
This study was submitted and approved by the Ethics Committee of Armed Forces
Hospital (see Institutional Review Board Statement on page 10).
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Table 1. Description of the translation process adapted from Beaton et al. [20].
Stage Action Descriptive
I Initial translation(Translation 1 + Translation 2)
In this stage, two independent translations were conducted, from the original
language to the target language, in this case, from American English (USA)
to European Portuguese (EU), by bilingual translators, whose mother tongue
is Portuguese (EU). One of the translators was considered naïve (not having
knowledge of the subject under study), thus allowing a translation that
reflects the language used by common sense. In this version, it was expected
that different meanings would be detected when compared to the other
version. The other translator was familiar with the concepts and meanings of
the subject under study (OM). This translation sought to provide more
reliable equivalences to clinical traits. At the end of this process, reports of
each translation were developed, identifying the ambiguity.
II Summary of translated versions(T1 + T2)
Here, the translators of the T1 and T2 versions of the OnyCOE-tTM
questionnaire met to resolve discrepancies and measure the semantic content,
to produce the translated version, T-12, of the translation questionnaire (T1 +
T2). The divergences were compared and identified until a consensus was
reached, always considering the original questionnaire. This meeting was
attended by the researcher responsible for the translation and adaptation of
the scale for the Portuguese population, which synthesized the opinions
resulting from the two translations, giving rise to the consensual version of
the questionnaire. The methodology used at the meeting included a full
reading of the original questionnaire, sentence by sentence, in which the
translators compared their translated versions, in search of a semantic and
syntactic consensus. The responsible researcher moderated the dynamics of
the meeting and created the T-12 version. Notwithstanding unanimity in
translation, there were some situations in which more than one form of
translation was assumed to be correct, which also allowed for changes. This
process resulted in the merger of the two versions known as (T-12). As the
previous phase, a report was prepared that identified the situations that
generated doubts and the options decided.
III Back-translation
From the T-12 version, two back-translations were performed. The BT1 and
BT2 were produced by translators with the mother tongue of the original
questionnaire (USA). As in the previous steps, a report was produced for
each translated version. This third step allowed confirmation of the validity
and ensured that the translated version reflected the content of the original
version. It also allowed for detecting the presence of inconsistencies and/or
conceptual errors in the primary translation.
IV Expert Committee Review
The expert committee intended to achieve intercultural equivalence. It was
intended to consolidate all versions of the questionnaire and to develop the
pretest version. The expert committee consisted of health professionals,
translators and language professionals, as recommended by the guideline.
They reviewed all translations (T1, T2, T12, BT1, BT2) to reach consensus and
eliminated any discrepancies that may have still existed. It was decided to
obtain equivalence between the original version and the final version with
regard to semantics, languages, life experiences and concepts.
V Pretest of the Prefinal version
The pretest was applied to a convenience sample of hospital patients with
OM (n = 49). The requirement of the guideline translation protocol (to be
applied to 30–40 people) was met.
VI Submission of the final versionto authors
Although the owners of the instrument have always followed the translation
and validation process, in order to comply with the adopted guide, the final
version was sent to the authors, and the data were treated in SPSS v.26. This
verification of the final version by the owners thus served as an additional
measure to ensure that the properties of the original instrument were present
in the translation performed.
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Statistical Analysis
Statistical analysis was performed using the IBM SPSS Statistics program (version 26). The
sample was characterized, including mean, standard deviation and percentages through
descriptive analysis. Lastly, the sample studied was small and did not allow an appropriate
analysis of the psychometric characteristics. Therefore, such analysis will be performed in
a different study.
3. Results
This study was carried out with 49 patients of the Hospital das Forças Armadas, Polo
Porto, between January and December 2019. The majority were married 38/49 (78%),
lived in the district of Porto (Portugal) 38/49 (78%) and attended podiatry consultations
30/49 (61%). About one-fifth of the sample was diabetic 10/49 (20%). Table 2 shows the
demographic and clinical data obtained.
Table 2. Demographic and clinical data.
Age n = 49 (%)
Mean 66 years (SD = 16.24; min 19–max 90)
≥ 18 ≤ 40 6/49 (12%)
> 40 ≤ 60 13/49 (27%)
>60 30/49 (61%)
Sex n = 49 (%)
Female 16/49 (33%)
Male 33/49 (67%)
Education n = 49 (%)
Basic education first cycle 15/49 (31%)
Basic education second and third cycle 10/49 (20%)
Secondary education 18/49 (37%)
Higher education 6/49 (12%)





Impact on quality of life n = 49 (%)
Caregiver needed 29/49 (59%)
Daily hygiene for feet 38/49 (78%)
Self-care difficulties 34/49 (69%)
Shame/embarrassment 26/49 (53%)
Concern 39/49 (80%)
Onychomycosis prevalence n = 49 (%)
Onychomycosis for more than 5 years 24/49 (49%)
Laboratory diagnosis (KOH + culture) 32/49 (65%)
The results of this translation and cross-cultural adaptation process are presented in
stages. We highlight only the results adopted after the discussion between translators,
researchers and health professionals, in the different stages in which they were involved.
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3.1. Results of Stages I and II
The initial translations and synthesis were performed in a single version (T12), and
the results are summarized in Table 3.
Table 3. The original and translated proposed version of the OnyCOE-tTM.
Original Version (English USA) Translated Version (Portuguese EU)
Question 1 (b) “Soreness, redness or swelling of your toesor toenails”
“Desconforto vermelhidão ou inchaço dos dedos
ou das unhas dos pés”
Question 1 (c) “Thickening or swelling of your toes or toenails” Espessamento ou inchaço dos dedos ou das unhasdos pés”
Question 2
“During the PAST 4 WEEKS, how much of a
problem were the following because of your nail
fungal condition?”
“Durante as ÚLTIMAS 4 SEMANAS, em que
medida as situações a seguir apresentadas foram
um problema e ou dificuldade devido à sua
doença fúngica das unhas?”
Likert scale “Somewhat of a problem?” “Moderadamente problemático”
Item (c) “Being embarrassed by the appearance ofyour nails?”
“Estar envergonhado/a com o aspeto das
suas unhas?”
item (d) “Feeling self-conscious about the appearance ofyour nails?”
“Sentir-se constrangido/a com o aspeto das
suas unhas?”
item (f) Feeling that people may see you as uncleanor untidy?”
“Sentir que as pessoas o/a pudessem ver como
pouco limpo/a ou desleixado/a?”
item (i)
“Doing activities that require you to go barefoot in
public (such as swimming, going to the beach,
getting into a hot tub, or working out at a
health club)?”
“Realizar atividades que implicam andar
descalço/a em público (tais como nadar, ir à praia,
entrar numa banheira de hidromassagem, ou
treinar num ginásio)?”
item (j)
“Doing any hobbies that require a lot of time on
your feet (such as jogging, golfing, playing tennis
or dancing)?”
“Realizar atividades de lazer que implicam estar
muito tempo de pé (tais como correr, jogar golfe,
jogar ténis ou dançar)?”
item (k)
“Performing daily activities that require you to be
on your feet a lot (such as waiting tables, working
as a cashier or salesperson, making deliveries, or
construction work)?”
“Desempenhar atividades diárias que exijam que
esteja muito tempo de pé (tais como servir à mesa,
trabalhar como caixa ou vendedor, fazer entregas,
ou trabalhar na construção)?”
In the statement before
the 3rd question
“Some people with onychomycosis (nail fungal
condition) report being bothered by the following
situations. Please answer the following according
to how closely you feel these situations
describe you.”
“Algumas pessoas com onicomicose (doença
fúngica das unhas) referem sentir-se incomodadas
pelas situações seguintes. Por favor tenha em
conta na sua resposta o quão aproximadamente
considera que estas situações o/a descrevem.”
In the statement before
the 4rd question
“The following questions ask you to assess your
satisfaction with your nail treatment program
(Circle one number on each line).”
“As seguintes questões solicitam-lhe que avalie o
seu grau de satisfação com o seu plano de
tratamento das unhas (Assinale com um círculo
um número em cada linha).”
3.2. Results of Stage III
In stage III, two back-translations were performed by two translators whose mother
tongue was that of the original questionnaire (American English). These translators were
not specialists in clinical terminology and did not know the original questionnaire, avoiding
translation bias. It was found that the back-translations were direct, with no significant
doubts of the terminology. Whenever possible, it was decided to introduce the simplest
terms, in order to facilitate the application of the questionnaire to people with less education.
Although the two versions that resulted from the back-translation were similar to the
original version, some words and/or expressions presented several possible translation
options, which are highlighted in Table 4.
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These two terms have very similar meanings, presenting a
challenge as to discerning which specific, equivalent emotion the
researchers wanted to ask respondents about. I chose to translate
constrangido as “embarrassed” and envergonhado as “ashamed”.
They are similar feelings, but the latter is more serious and implies
stronger social judgement and personal culpability.
Assinalar
Without seeing the visual context of this term, I had translated it
as “mark” or “note”, but after seeing that in one instance it was
referring to a check box, it became “check the box”, and in other
instances, “circle”.
Doença fúngica das unhas
The literal translation of this term would be “fungal nail disease”,
but a quick search revealed that the more common term in English
is “fungal nail infection”.
3.3. Results of Stage IV
In stage IV, the analysis and validation by the expert committee was carried out. After
revision and corrections suggested by the owners of the original questionnaire, specialists
(teachers/English translators, health professionals and researchers) were consulted. The
documents under analysis were sent to all experts, namely the original questionnaire, the
T12 questionnaire and the file to assess the identified discrepancies. Suggestions and cor-
rections were requested from each specialist individually, after each opinion the necessary
changes were made, and the prefinal version was made available to all. Consensus was
reached on all items listed in Table 5.
Table 5. Expert committee review of the original and translated version adopted of the OnyCOE-tTM.
Original Version (English USA) Translated Version AdoptedPortuguese (EU)
Question 1
“1. Please answer the following
questions regarding problems you may
have had in the PAST 4 WEEKS with
your nail fungal condition. Answer
each question completely by indicating
BOTH: I–HOW MUCH OF THE
TIME you experienced the problem,
and then II–HOW BOTHERED you
were by the problem. (If you are unsure
about how to answer a question, give
the best answer you can.) TOENAILS”
“1. Por favor, responda às seguintes
perguntas sobre os problemas que teve nas
ÚLTIMAS 4 SEMANAS com a sua doença
fúngica das unhas. Responda a cada
questão na totalidade indicando: I–COM
QUE FREQUÊNCIA sentiu os problemas
indicados na tabela, e, em seguida,
II–QUÃO INCOMODADO se sentiu com
os problemas indicados na tabela. Note que,
quando nos referimos a incomodado
queremos dizer quão preocupado ou
aborrecido se sentiu. (Se não tiver a certeza
relativamente a alguma das questões,
assinale a resposta que lhe parece mais
apropriada.) PROBLEMAS COM AS
UNHAS DOS PÉS”
Item (f) “Deformity or disfigurement ofyour toenails”
“Deformação ou alteração do formato das
unhas dos pés”
Int. J. Environ. Res. Public Health 2021, 18, 5793 7 of 10
Table 5. Cont.
Original Version (English USA) Translated Version AdoptedPortuguese (EU)
Question 2
“During the PAST 4 WEEKS, how
much of a problem were the following
because of your nail fungal condition?”
“Considerando a sua doença fúngica das
unhas, durante AS ÚLTIMAS 4
SEMANAS, indique quão problemático
foram as seguintes situações: (Assinale com
um círculo um número em cada linha)”
NOTE: As the statement is no longer in interrogative form, the items (a) to (p) are now affirmative.
Item (c) “Being embarrassed by the appearanceof your nails?”
Sentir vergonha com o aspeto das
suas unhas.”
item (d) “Feeling self-conscious about theappearance of your nails?”
“Reconhecer ou tomar consciência do
aspeto das suas unhas.”
item (f) “Feeling that people may see you asunclean or untidy?”
“Sentir que as pessoas o/a pudessem ver
como pouco limpo/a e desleixado/a.”
item (o) “Concern about concealing your nails,or keeping your shoes on?”
“Preocupação em esconder as suas unhas,
ou manter-se calçado.”
item (p) “Overall, how much of a problem isyour nail condition in your life?”
“A sua doença das unhas, em geral,
constitui um problema na sua vida.”
Question 3
Item (f)
“I feel self-conscious and embarrassed
in public.”
“Sinto conscientemente o meu problema e
sinto-me envergonhado em público.”
3.4. Results of Stage V
The pretest version was applied to 49 participants. They were asked about the meaning
of each item and if they understood what was being asked. The distribution of responses
was examined, and items with no response were identified. Overall, 44/49 (90%) par-
ticipants did not report any difficulty in filling it out. Approximately 5/49 (10%) older
participants, with low education, said that the questionnaire was long, and only two
questions raised doubts, identified in Table 6.
Table 6. After the pretest version.
Questions Problems Identified in Pretest Version
Questão 1
I. Nas últimas 4 semanas, com que frequência teve os
seguintes problemas?
Item (g) Outros, especifique
In this question, 4/49 (8%) of the participants attributed the score, but
did not specify the problem.
Questão 4
As seguintes questões solicitam-lhe que avalie o seu grau de
satisfação com o seu plano de tratamento das unhas
(Assinale com um círculo um número em cada linha)
Assinale aqui se ainda não teve tratamento:
Some participants had difficulty understanding whether the treatment
plan they had already carried out was framed (for example, systemic
treatment with oral medication; topical treatment with varnish or
solution; debridement; consultation in dermatology, podiatry). Some
participants had already undergone several unsuccessful treatments
13/49 (27%), others had not yet undergone any treatment 24/49 (49%),
and as they knew we were doing research in this area, they came in
search of treatment for onychomycosis. Most of the 25/49 participants
(51%) who reported not having had treatment did not reach the level of
satisfaction with the treatment plan; however, approximately 11/49
participants (22%), although they reported not having had treatment,
decided to answer questions about the degree of satisfaction.
Overall questionnaire
In all questionnaires, the missing responses were only 1 to 3/49 (2 to 6%).
In 6% of the questionnaires, one item was not answered. In 4% of the
questionnaires, two items were not answered. In 2% of the
questionnaires, three items were not answered.
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4. Discussion
In this study, a translation and cross-cultural adaptation of the OnyCOE-tTM trans-
lated scale was performed. Overall, no major difficulties were found by the researchers
and translators in the six-step translation and adaption process. A small number of se-
mantic and syntactic problems had to be resolved. We highlight these items: “Being
embarrassed by the appearance of your nails” and “Feeling self-conscious about the ap-
pearance of your nails” that generated more doubts since the initial translations were not
consensual. This occurred because “Being embarrassed” could be translated as “Estar
constrangido/Estar envergonhado”, and “Feeling self-conscious” could be translated as
“Sentir-se constrangido/Reconhecer ou tomar consciência”. The versions that, from a
semantic point of view, were considered to be easier to understand by Portuguese people
(EU) were “Sentir vergonha com o aspeto das suas unhas” and “Reconhecer ou tomar
consciência do aspeto das suas unhas”, respectively. From the syntactic point of view,
the wording of question two and all associated items were changed from interrogative to
affirmative, to facilitate their understanding. We kept question four, referring to the degree
of satisfaction (which was optional in the answer), because it may allow for assessment of
another dimension in the care of these patients in future studies.
The final version was named Questionário sobre a Qualidade de vida–Onicomicose
(doença fúngica das unhas). This is the first QOL instrument for patients with OM, trans-
lated and adapted to Portuguese (EU). In the semantic adaptation, we sought to gain
knowledge into the characteristics of the Portuguese population, in particular, regarding
the lower levels of literacy, from the perspective of OM’s effect on patients’ QOL. The values
that reflect aspects associated with the impact of OM on QOL, shame/embarrassment
(53%) and concern (80%), are in line with previous studies [15].
A small, non-representative sample was studied. Therefore, the psychometric char-
acteristics of the translated scale could not be properly evaluated. Performing additional
studies, with larger samples and different realities compared to this study, can improve
our detailed knowledge on construct validity, reliability and response patterns. In addi-
tion, it should be noted that the best cross-cultural adaptation method is still a matter of
debate [21]. This means that the results of the present study may be influenced by the
particular method chosen.
The present study of translation and adaptation is only the first step to test the
psychometric properties of this instrument in larger samples of the Portuguese population.
The present questionnaire will allow a better understanding of the impact of OM on
patients’ QOL, which may facilitate the identification of more effective and personalized
care strategies [22,23].
5. Conclusions
The translation and cross-cultural adaptation of the OnyCOE-tTM questionnaire, in
Portuguese “Questionário sobre a Qualidade de vida–Onicomicose (doença fúngica das
unhas)”, suggests that it may be used for further studies to test validity and reliability
in this population. The translated questionnaire demonstrated semantic equivalence
to the original. The original authors, collaborating experts and the patients with OM
demonstrated acceptance of the questionnaire. Further studies with larger samples are
required for a full validation of the questionnaire.
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